Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant
Clinical trial NCT03922061 · COMPLETED
Trial details
- NCT number
- NCT03922061
- Sponsor
- University of Vermont
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-19
- Primary completion
- 2019-07-18
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.